|
|||||
|
|
Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. |
|
| Authors: | Douglas Shaffer Marian Butterfield Carol Pamer Ann Corken Mackey |
| Institution: | Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD 20857, USA. |
| Abstract: | |
| Keywords: | |